gsk2586184 and Chemical-and-Drug-Induced-Liver-Injury

gsk2586184 has been researched along with Chemical-and-Drug-Induced-Liver-Injury* in 1 studies

Trials

1 trial(s) available for gsk2586184 and Chemical-and-Drug-Induced-Liver-Injury

Article	Year
DRESS syndrome and reversible liver function abnormalities in patients with systemic lupus erythematosus treated with the highly selective JAK-1 inhibitor GSK2586184. Lupus, 2015, Volume: 24, Issue:6 Topics: Adult; Azetidines; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity Syndrome; Female; Humans; Janus Kinase 1; Lupus Erythematosus, Systemic; Middle Aged; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Triazoles	2015

Article

Year

DRESS syndrome and reversible liver function abnormalities in patients with systemic lupus erythematosus treated with the highly selective JAK-1 inhibitor GSK2586184.

Lupus, 2015, Volume: 24, Issue:6

Topics: Adult; Azetidines; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity Syndrome; Female; Humans; Janus Kinase 1; Lupus Erythematosus, Systemic; Middle Aged; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Triazoles

2015